Peter Carlson
@PeterCarlsonMD
Followers
64
Following
55
Media
0
Statuses
16
PGY2 in Pediatrics at Seattle Children's Hospital, interested in cancer immunotherapy and pediatric oncology. Alum of @UWMSTP in Wisconsin
Joined October 2019
RT @sitcancer: SITC is deeply concerned by the announcement from NIH that will cut billions of dollars in indirect costs. We urge the NIH &….
0
22
0
Excited to share my work with @ZachMorrisMDPhD and @RPatelMDPHD showing that we can use low-dose systemic molecular targeted radionuclide therapy to enhance immune responses to local solid tumor vaccines!.
New #JITC article: Radiation to all macroscopic sites of tumor permits greater systemic antitumor response to in situ vaccination @PeterCarlsonMD @PiepsTweeets
1
2
14
RT @_Nick_Arp: "Experience around the world has demonstrated that restricting access to legal abortion care does not substantially reduce t….
nejm.org
The editors strongly condemn the U.S. Supreme Court’s decision to abolish longstanding legal protections by reversing Roe v. Wade.
0
1
0
RT @jitcancer: New #JITC article: Short-course neoadjuvant in situ vaccination for murine melanoma .
0
4
0
RT @UWMSTP: #PubAlert #TeamScience! MSTP students & alums: M4 @PiepsTweeets G4 @JJagodinsky & MSTP alum @PeterCarlsonMD published in @Front….
pubmed.ncbi.nlm.nih.gov
RT significantly improves the local anti-tumor effect of the in situ vaccine CpG+OX40 in immunologically "cold", solid, murine tumor models where RT or CpG+OX40 alone fail to stimulate tumor regres...
0
1
0
RT @RPatelMDPHD: Excited to share our new publication which shows that low dose radiopharmaceutical therapy can enhance efficacy of immune….
0
35
0
RT @PiepsTweeets: Really proud of the work our team put into this manuscript recently published by @jitcancer! Thanks to the strong collabo….
0
2
0
RT @jitcancer: New #JITC article: Association between body mass index, dosing strategy, and efficacy of immune checkpoint inhibitors @murta….
0
2
0
RT @WiscPediatrics: Four @uwsmph researchers have received prestigious awards from the @ACTScience, including one of @WiscPediatrics very o….
pediatrics.wisc.edu
Four University of Wisconsin School of Medicine and Public Health researchers have been honored with prestigious awards from the Association for Clinical and Translational Science (ACTS), in recogn...
0
2
0
RT @WiscPediatrics: Dr. Anna Huttenlocher was recently awarded a two-year grant from @NIH-@niaid for her project, “Imaging Immunometabolism….
pediatrics.wisc.edu
Anna Huttenlocher, MD, professor, Pediatric Rheumatology, was recently awarded a two-year R21 grant for $422,720 from the National Institutes of Health, National Institute of Allergy and Infectious...
0
2
0
Very happy to see our new publication up now on @jitcancer - a simple and effective means of improving variability in implanted mouse tumor models for immunotherapy - depth makes a big difference! Thank you to @RPatelMDPHD @ZachMorrisMDPhD @matrodmed.
New #JITC article: Depth of tumor implantation affects response to in situ vaccination in a syngeneic murine melanoma model
0
2
12
RT @UWMSTP: Congratulations again- so proud of you all!! <3 your MSTP! #MatchDay2021 @uwsmph #doubledocs .@PeterCarlsonMD @Cenilicus @Ameli….
0
5
0
RT @WiscPediatrics: Drs Capitini, DeSantes, Erbe-Gurel, Hank, Huttenlocher, Otto, Rakhmilevich, Sondel and @UWCarbone researchers were rece….
pediatrics.wisc.edu
Congratulations to Christian Capitini, MD, Kenneth DeSantes, MD, Amy Erbe-Gurel, PhD, Jacquelyn Hank, PhD, Anna Huttenlocher, MD, Mario Otto, MD, PhD, Alexander Rakhmilevich, MD, PhD, Paul Sondel,...
0
1
0
RT @jitcancer: New #JITC article: Identification of neuroblastoma cell lines with uncommon TAZ+/mesenchymal stromal cell phenotype with str….
0
4
0